Tratamiento de la hipercolesterolemia familiar heterocigota en la infancia y la adolescencia: un problema no resuelto
Authors:
- Fernando CiveiraFCFernando Civeira
- Nuria PlanaNPNuria Plana
- 1 June 2017
- journal article
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 70 (6) , 423-424
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Homozygous Familial Hypercholesterolemia in SpainCirculation: Cardiovascular Genetics, 2016
- Necesidades no cubiertas con el tratamiento hipolipemiante oral: documento de posición de la Sociedad Española de CardiologíaRevista Espanola de Cardiologia, 2016
- Statins in Familial HypercholesterolemiaJACC, 2016
- The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in HepatocytesThe Journal of Clinical Endocrinology & Metabolism, 2016
- Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010Journal of the American Heart Association, 2014
- Consenso de expertos sobre la detección y el manejo clínico de la hipercolesterolemia familiarClínica e Investigación en Arteriosclerosis, 2013
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patientsJournal of Clinical Lipidology, 2011
- Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemiaAtherosclerosis, 2004
- Association of Coronary Heart Disease Risk Factors With Microscopic Qualities of Coronary Atherosclerosis in YouthCirculation, 2000